Patents by Inventor Jun Anabuki

Jun Anabuki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Concomitant pharmaceutical agents and use thereof
    Patent number: 8754032
    Abstract: A concomitant agent to be used simultaneously or separately, comprising a combination of (a) 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine, a salt of the compound with an organic or inorganic and mono- or di-basic acid or a solvate thereof, and (b) at least one kind of active ingredient selected from the group consisting of an active ingredient of a pharmaceutical agent selected from (i) an antidiabetic drug, (ii) a lipid lowering drug, (iii) an antihypertensive drug, (iv) a therapeutic drug for diabetic complications, (v) an antiobesity drug, (vi) an antiplatelet drug and (vii) an anticoagulant, a pharmaceutically acceptable salt thereof and a solvate thereof.
    Type: Grant
    Filed: June 2, 2006
    Date of Patent: June 17, 2014
    Assignee: Mitsubishi Tanabe Pharma Corporation
    Inventors: Yuji Abe, Jun Anabuki, Fumihiko Akahoshi
  • CONCOMITANT PHARMACEUTICAL AGENTS AND USE THEREOF
    Publication number: 20090082256
    Abstract: A concomitant agent to be used simultaneously or separately, comprising a combination of (a) 3-{(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine, a salt of the compound with an organic or inorganic and mono- or di-basic acid or a solvate thereof, and (b) at least one kind of active ingredient selected from the group consisting of an active ingredient of a pharmaceutical agent selected from (i) an antidiabetic drug, (ii) a lipid lowering drug, (iii) an antihypertensive drug, (iv) a therapeutic drug for diabetic complications, (v) an antiobesity drug, (vi) an antiplatelet drug and (vii) an anticoagulant, a pharmaceutically acceptable salt thereof and a solvate thereof.
    Type: Application
    Filed: June 2, 2006
    Publication date: March 26, 2009
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Yuji Abe, Jun Anabuki, Fumihiko Akahoshi
  • 1/2 sulfate of a [(S) -1- [(S) -2- [(trans-4- aminocyclohexylmethyl) carbamoyl]pyrrolidine-1-carbonyl]- 2-isopropylthio-2-methylpropyl]carbamic acid propyl ester
    Patent number: 6117897
    Abstract: A 1/2 sulfate of a [(S)-1-[(S)-2-[(trans-4-aminocyclohexylmethyl) carbamoyl]pyrrolidine-1-carbonyl]-2-isopropylthio-2-methylpropyl]carbamic acid propyl ester represented by the following formula (I): a hydrate or solvate thereof.
    Type: Grant
    Filed: November 18, 1998
    Date of Patent: September 12, 2000
    Assignee: Mitsubishi Chemical Corporation
    Inventors: Norimichi Iwase, Naoto Inakoshi, Koichi Sugawara, Jun Anabuki